Skip to main content

Table 2 Summary data on observed copy number variations

From: Identification of genomic copy number variations associated with specific clinical features of head and neck cancer

 

#

Pathogenic (%)

Benign (%)

Unknown (%)

Log2 range

Size range (bp)

Gains

438

321 (73.3%)

24 (5.5%)

93 (21.2%)

0.22 -- 2.82

20,486–155,171,772

Losses

251

162 (64.5%)

26 (10.4%)

63 (25.1%)

−3.62 -- -0.25

23,615–127,293,063

  1. 2/64 samples without CNVs: male, oropharynx, stage IVA, pT4pN2, survival time 45 months; female, tongue, stage II, pT2pN0, alive after 40 months